TSS
AZN icon

Two Sigma Securities’s AstraZeneca AZN Stock Holding History

Two Sigma Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,750
Closed -$2.14M – 2855
2024
Q2 		$2.14M Sell
13,750
-15,550
-53% -$2.34M 0.03% 684
2024
Q1 		$3.97M Buy
29,300
+600
+2% +$79.5K 0.04% 476
2023
Q4 		$3.87M Buy
28,700
+3,400
+13% +$442K 0.04% 449
2023
Q3 		$3.43M Buy
25,300
+23,850
+1,645% +$3.26M 0.04% 482
2023
Q2 		$208K Sell
1,450
-8,300
-85% -$1.22M ﹤0.01% 2193
2023
Q1 		$1.35M Buy
9,750
+5,150
+112% +$693K 0.03% 687
2022
Q4 		$624K Buy
+4,600
New +$577K 0.02% 943
2021
Q4 		– Sell
-10,300
Closed -$1.24M – 1543
2021
Q3 		$1.24M Buy
10,300
+1,600
+18% +$186K 0.04% 425
2021
Q2 		$1.04M Buy
+8,700
New +$955K 0.03% 396
2021
Q1 		– Sell
-62,350
Closed -$6.23M – 877
2020
Q4 		$6.23M Buy
62,350
+59,450
+2,050% +$6.3M 0.15% 80
2020
Q3 		$318K Buy
+2,900
New +$323K 0.01% 827
2020
Q1 		– Sell
-6,100
Closed -$608K – 1377
2019
Q4 		$608K Buy
6,100
+1,750
+40% +$165K ﹤0.01% 1331
2019
Q3 		$388K Buy
4,350
+1,300
+43% +$113K ﹤0.01% 1375
2019
Q2 		$252K Buy
+3,050
New +$239K ﹤0.01% 1561
2019
Q1 		– Sell
-7,200
Closed -$547K – 1826
2018
Q4 		$547K Sell
7,200
-19,150
-73% -$1.5M 0.01% 947
2018
Q3 		$2.08M Sell
26,350
-39,500
-60% -$2.99M 0.01% 695
2018
Q2 		$4.62M Buy
65,850
+13,100
+25% +$942K 0.02% 519
2018
Q1 		$3.69M Buy
52,750
+49,400
+1,475% +$3.42M 0.02% 594
2017
Q4 		$232K Buy
+3,350
New +$226K 0.01% 1191

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Two Sigma Securities's AZN Position: Q2 2026 in Review

Two Sigma Securities sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 3,201 shares — an estimated $631K sold.

Two Sigma Securities first reported a position in AZN in Q1 2018 and held it in 20 quarters. The position peaked at $13.3M in Q3 2024. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Two Sigma Securities reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 3,201 AstraZeneca shares in Q2 2026, an estimated $631K.
  • Two Sigma Securities first reported a position in AstraZeneca in Q1 2018 and held it in 20 quarters.
  • Two Sigma Securities's AstraZeneca position peaked at $13.3M in Q3 2024.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.